FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule

 

Advisory Committees

Nature and Basis Statements of Conflict(s) of Interest for Voting Members of FDA Advisory Committee Members

The Agency is revising its procedures regarding the disclosure of conflicts of interest and waivers for voting advisory committee members in order to implement the requirements of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2006) (Nov. 10, 2005). This information is being provided as an interim measure to comply with the requirements of this law.

Transmissible Spongiform Encephalopathies Advisory Committee

September 18, 2006

Val D. Bias

  • 18 U.S.C. 208 waiver [pdf]

Ronald S. Brookmeyer, Ph.D.

  • 18 U.S.C. 208 waiver [pdf]

Lynn H. Creekmore, D.V.M.

  • 18 U.S.C. 208 waiver [pdf]

Michael Geschwind, M.D., Ph.D..

  • 18 U.S.C. 208 waiver [pdf]

Bernardino Ghetti, M.D. (Did not attend meeting.)

  • 18 U.S.C. 208 waiver [pdf]

R. Nick Hogan, Ph.D., M.D.

  • 18 U.S.C. 208 waiver [pdf]

Florence Kranitz

  • 18 U.S.C. 208 waiver [pdf]

James W. Lillard, Jr., Ph.D.

  • 18 U.S.C. 208 waiver [pdf]

Laura K. Manuelidis, M.D.

  • 18 U.S.C. 208 waiver [pdf]

James A. Mastrianni, M.D., Ph.D.

  • 18 U.S.C. 208 waiver [pdf]

Mo D. Salman, D.V.M., Ph.D.

  • 18 U.S.C. 208 waiver [pdf]

Glenn C. Telling, Ph.D.

  • 18 U.S.C. 208 waiver [pdf]

Page updated: October 16, 2006